For Patients
Identifying the link can lead to a crucial diagnosis
Hereditary ATTR amyloidosis is a rapidly progressive disease that may eventually rob patients of function—and their lives.1-4
Find out how you can help accelerate time to diagnosis.
A genetic screening option offered at no charge
Learn about Alnylam Act®
Resources for healthcare providers
Find additional information about identifying hATTR amyloidosis
Sign up to receive updates
Stay up-to-date on news about hATTR amyloidosis
*Required Fields
By clicking submit, you certify that you are a US healthcare professional.
Your submission has been received.
Return to site
You will be directed to a website for a medicine that treats the polyneuropathy caused by an illness called hereditary transthyretin-mediated (hATTR) amyloidosis.
